Sanofi's Taxotere shown to help in stomach cancer (Reuters)


Reuters - The treatment of advanced stomach cancer
with a chemotherapy based on Sanofi-Aventis's Taxotere drug was
shown to reduce the risk of death by 23 percent, the company
said, citing an international study.

Read more...